DNA Donor Molecules Vastly Improves Precision Genome Enhancing in Caenorhabditiselegans
Christina
May 21, 2021
Melting dsDNA Donor Molecules Vastly Improves Precision Genome Enhancing in Caenorhabditiselegans
CRISPR genome modifying has revolutionized genetics in quite a few organisms. Contained in the nematode Caenorhabditiselegans one injection into every of the 2 gonad arms of an grownup hermaphrodite exposes tons of of meiotic germ cells to modifying mixtures, allowing the restoration of loads of indels or small precision edits from every successfully injected animal. Sadly, significantly for extended insertions, modifying efficiencies can differ broadly, necessitating loads of injections, and customarily requiring co-selection methods.
Correct proper right here we present that melting double stranded DNA (dsDNA) donor molecules earlier to injection will enhance the frequency of tangible homology-directed restore (HDR) by loads of fold for longer edits. We describe troubleshooting methods that allow persistently excessive modifying efficiencies ensuing, as an illustration, in as lots as 100 unbiased GFP knock-ins from a single injected animal. These efficiencies make C. elegans by far the very best metazoan to genome edit, eradicating limitations to the use and adoption of this facile system as a mannequin for understanding animal biology.
agresearchforum
Vav 1 Oncogene (VAV1) Polyclonal Antibody |
MBS2032848-05mL |
MyBiosource |
0.5mL |
EUR 365 |
Vav 1 Oncogene (VAV1) Polyclonal Antibody |
MBS2032848-1mL |
MyBiosource |
1mL |
EUR 445 |
Vav 1 Oncogene (VAV1) Polyclonal Antibody |
MBS2032848-5mL |
MyBiosource |
5mL |
EUR 1220 |
Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
PAC213Hu01 |
Cloud-Clone |
100ul |
EUR 245 |
|
Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
PAC213Mu01 |
Cloud-Clone |
100ul |
EUR 252 |
|
Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2027967-01mL |
MyBiosource |
0.1mL |
EUR 175 |
Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2027967-02mL |
MyBiosource |
0.2mL |
EUR 220 |
Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2027967-05mL |
MyBiosource |
0.5mL |
EUR 355 |
Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2027967-1mL |
MyBiosource |
1mL |
EUR 435 |
Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2027967-5mL |
MyBiosource |
5mL |
EUR 1185 |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Human) |
4-PAC213Hu01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Vav 1 Oncogene (VAV1) |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Mouse) |
4-PAC213Mu01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Vav 1 Oncogene (VAV1) |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Human), PE |
4-PAC213Hu01-PE |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Vav 1 Oncogene (VAV1). This antibody is labeled with PE. |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Mouse), PE |
4-PAC213Mu01-PE |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Vav 1 Oncogene (VAV1). This antibody is labeled with PE. |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Human), APC |
4-PAC213Hu01-APC |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Vav 1 Oncogene (VAV1). This antibody is labeled with APC. |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Human), Cy3 |
4-PAC213Hu01-Cy3 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Vav 1 Oncogene (VAV1). This antibody is labeled with Cy3. |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Human), HRP |
4-PAC213Hu01-HRP |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Vav 1 Oncogene (VAV1). This antibody is labeled with HRP. |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Mouse), APC |
4-PAC213Mu01-APC |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Vav 1 Oncogene (VAV1). This antibody is labeled with APC. |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Mouse), Cy3 |
4-PAC213Mu01-Cy3 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Vav 1 Oncogene (VAV1). This antibody is labeled with Cy3. |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Mouse), HRP |
4-PAC213Mu01-HRP |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Vav 1 Oncogene (VAV1). This antibody is labeled with HRP. |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Human), FITC |
4-PAC213Hu01-FITC |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Vav 1 Oncogene (VAV1). This antibody is labeled with FITC. |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Mouse), FITC |
4-PAC213Mu01-FITC |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Vav 1 Oncogene (VAV1). This antibody is labeled with FITC. |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Human), Biotinylated |
4-PAC213Hu01-Biotin |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Vav 1 Oncogene (VAV1). This antibody is labeled with Biotin. |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Mouse), Biotinylated |
4-PAC213Mu01-Biotin |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Vav 1 Oncogene (VAV1). This antibody is labeled with Biotin. |
PE-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064027-01mL |
MyBiosource |
0.1mL |
EUR 265 |
PE-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064027-02mL |
MyBiosource |
0.2mL |
EUR 355 |
PE-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064027-05mL |
MyBiosource |
0.5mL |
EUR 660 |
PE-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064027-1mL |
MyBiosource |
1mL |
EUR 810 |
PE-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064027-5mL |
MyBiosource |
5mL |
EUR 2330 |
PE-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064033-01mL |
MyBiosource |
0.1mL |
EUR 275 |
PE-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064033-02mL |
MyBiosource |
0.2mL |
EUR 365 |
PE-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064033-05mL |
MyBiosource |
0.5mL |
EUR 675 |
PE-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064033-1mL |
MyBiosource |
1mL |
EUR 835 |
PE-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064033-5mL |
MyBiosource |
5mL |
EUR 2395 |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Human), APC-Cy7 |
4-PAC213Hu01-APC-Cy7 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Vav 1 Oncogene (VAV1). This antibody is labeled with APC-Cy7. |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Mouse), APC-Cy7 |
4-PAC213Mu01-APC-Cy7 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Vav 1 Oncogene (VAV1). This antibody is labeled with APC-Cy7. |
APC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064028-01mL |
MyBiosource |
0.1mL |
EUR 265 |
APC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064028-02mL |
MyBiosource |
0.2mL |
EUR 355 |
APC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064028-05mL |
MyBiosource |
0.5mL |
EUR 660 |
APC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064028-1mL |
MyBiosource |
1mL |
EUR 810 |
APC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064028-5mL |
MyBiosource |
5mL |
EUR 2330 |
Cy3-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064029-01mL |
MyBiosource |
0.1mL |
EUR 265 |
Cy3-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064029-02mL |
MyBiosource |
0.2mL |
EUR 355 |
Cy3-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064029-05mL |
MyBiosource |
0.5mL |
EUR 660 |
Cy3-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064029-1mL |
MyBiosource |
1mL |
EUR 810 |
Cy3-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064029-5mL |
MyBiosource |
5mL |
EUR 2330 |
HRP-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064031-01mL |
MyBiosource |
0.1mL |
EUR 205 |
HRP-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064031-02mL |
MyBiosource |
0.2mL |
EUR 255 |
HRP-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064031-05mL |
MyBiosource |
0.5mL |
EUR 450 |
HRP-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064031-1mL |
MyBiosource |
1mL |
EUR 545 |
HRP-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064031-5mL |
MyBiosource |
5mL |
EUR 1530 |
APC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064034-01mL |
MyBiosource |
0.1mL |
EUR 275 |
APC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064034-02mL |
MyBiosource |
0.2mL |
EUR 365 |
APC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064034-05mL |
MyBiosource |
0.5mL |
EUR 675 |
APC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064034-1mL |
MyBiosource |
1mL |
EUR 835 |
APC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064034-5mL |
MyBiosource |
5mL |
EUR 2395 |
Cy3-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064035-01mL |
MyBiosource |
0.1mL |
EUR 275 |
Cy3-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064035-02mL |
MyBiosource |
0.2mL |
EUR 365 |
Cy3-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064035-05mL |
MyBiosource |
0.5mL |
EUR 675 |
Cy3-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064035-1mL |
MyBiosource |
1mL |
EUR 835 |
Cy3-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064035-5mL |
MyBiosource |
5mL |
EUR 2395 |
HRP-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064037-01mL |
MyBiosource |
0.1mL |
EUR 205 |
HRP-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064037-02mL |
MyBiosource |
0.2mL |
EUR 260 |
HRP-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064037-05mL |
MyBiosource |
0.5mL |
EUR 460 |
HRP-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064037-1mL |
MyBiosource |
1mL |
EUR 560 |
HRP-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064037-5mL |
MyBiosource |
5mL |
EUR 1570 |
FITC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064030-01mL |
MyBiosource |
0.1mL |
EUR 215 |
FITC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064030-02mL |
MyBiosource |
0.2mL |
EUR 265 |
FITC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064030-05mL |
MyBiosource |
0.5mL |
EUR 480 |
FITC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064030-1mL |
MyBiosource |
1mL |
EUR 585 |
FITC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064030-5mL |
MyBiosource |
5mL |
EUR 1645 |
FITC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064036-01mL |
MyBiosource |
0.1mL |
EUR 220 |
FITC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064036-02mL |
MyBiosource |
0.2mL |
EUR 275 |
FITC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064036-05mL |
MyBiosource |
0.5mL |
EUR 490 |
FITC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064036-1mL |
MyBiosource |
1mL |
EUR 600 |
FITC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064036-5mL |
MyBiosource |
5mL |
EUR 1690 |
Biotin-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2094291-01mL |
MyBiosource |
0.1mL |
EUR 185 |
Biotin-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2094291-02mL |
MyBiosource |
0.2mL |
EUR 230 |
Biotin-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2094291-05mL |
MyBiosource |
0.5mL |
EUR 385 |
Biotin-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2094291-1mL |
MyBiosource |
1mL |
EUR 470 |
Biotin-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2094291-5mL |
MyBiosource |
5mL |
EUR 1300 |
Biotin-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2094292-01mL |
MyBiosource |
0.1mL |
EUR 190 |
Biotin-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2094292-02mL |
MyBiosource |
0.2mL |
EUR 230 |
Biotin-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2094292-05mL |
MyBiosource |
0.5mL |
EUR 395 |
Biotin-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2094292-1mL |
MyBiosource |
1mL |
EUR 485 |
Biotin-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2094292-5mL |
MyBiosource |
5mL |
EUR 1335 |
APC/CY7-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064026-1mL |
MyBiosource |
1mL |
EUR 1185 |
APC/CY7-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064026-5mL |
MyBiosource |
5mL |
EUR 3445 |
APC/CY7-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064026-5x5mL |
MyBiosource |
5x5mL |
EUR 15495 |
APC/CY7-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064032-1mL |
MyBiosource |
1mL |
EUR 1220 |
APC/CY7-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064032-5mL |
MyBiosource |
5mL |
EUR 3540 |
APC/CY7-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
MBS2064032-5x5mL |
MyBiosource |
5x5mL |
EUR 15930 |
Vav 1 Oncogene (VAV1) Antibody |
20-abx128450 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Vav 1 Oncogene (VAV1) Antibody |
20-abx131502 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Vav 1 Oncogene (VAV1) Antibody |
abx332110-100ul |
Abbexa |
100 ul |
EUR 510 |
|
Vav 1 Oncogene (VAV1) Antibody |
20-abx327434 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Vav 1 Oncogene (VAV1) Antibody |
20-abx327966 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Vav 1 Oncogene (VAV1) Antibody |
20-abx329103 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Vav 1 Oncogene (VAV1) Antibody |
abx331549-100ul |
Abbexa |
100 ul |
EUR 510 |
|
Vav 1 Oncogene (VAV1) Antibody |
abx327434-100g |
Abbexa |
100 µg |
EUR 250 |
Vav 1 Oncogene (VAV1) Antibody |
abx327434-50g |
Abbexa |
50 µg |
EUR 187.5 |
Vav 1 Oncogene (VAV1) Antibody |
abx327966-100g |
Abbexa |
100 µg |
EUR 250 |
Vav 1 Oncogene (VAV1) Antibody |
abx327966-50g |
Abbexa |
50 µg |
EUR 187.5 |
Vav 1 Oncogene (VAV1) Antibody |
abx329103-100l |
Abbexa |
100 µl |
EUR 187.5 |
Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
PAE929Hu01 |
Cloud-Clone |
100ul |
EUR 245 |
|
Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
PAE929Hu02 |
Cloud-Clone |
100ul |
EUR 245 |
|
Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2001848-01mL |
MyBiosource |
0.1mL |
EUR 175 |
Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2001848-02mL |
MyBiosource |
0.2mL |
EUR 220 |
Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2001848-05mL |
MyBiosource |
0.5mL |
EUR 355 |
Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2001848-1mL |
MyBiosource |
1mL |
EUR 435 |
Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2001848-5mL |
MyBiosource |
5mL |
EUR 1185 |
Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2007002-01mL |
MyBiosource |
0.1mL |
EUR 175 |
Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2007002-02mL |
MyBiosource |
0.2mL |
EUR 220 |
Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2007002-05mL |
MyBiosource |
0.5mL |
EUR 355 |
Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2007002-1mL |
MyBiosource |
1mL |
EUR 435 |
Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2007002-5mL |
MyBiosource |
5mL |
EUR 1185 |
Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human) |
4-PAE929Hu01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3) |
Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human) |
4-PAE929Hu02 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3) |
Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), PE |
4-PAE929Hu01-PE |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with PE. |
Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), PE |
4-PAE929Hu02-PE |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with PE. |
Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), APC |
4-PAE929Hu01-APC |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with APC. |
Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), Cy3 |
4-PAE929Hu01-Cy3 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with Cy3. |
Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), HRP |
4-PAE929Hu01-HRP |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with HRP. |
Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), APC |
4-PAE929Hu02-APC |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with APC. |
Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), Cy3 |
4-PAE929Hu02-Cy3 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with Cy3. |
Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), HRP |
4-PAE929Hu02-HRP |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with HRP. |
Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), FITC |
4-PAE929Hu01-FITC |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with FITC. |
Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), FITC |
4-PAE929Hu02-FITC |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with FITC. |
PE-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075868-01mL |
MyBiosource |
0.1mL |
EUR 265 |
PE-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075868-02mL |
MyBiosource |
0.2mL |
EUR 355 |
PE-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075868-05mL |
MyBiosource |
0.5mL |
EUR 660 |
PE-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075868-1mL |
MyBiosource |
1mL |
EUR 810 |
PE-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075868-5mL |
MyBiosource |
5mL |
EUR 2330 |
PE-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075869-01mL |
MyBiosource |
0.1mL |
EUR 265 |
PE-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075869-02mL |
MyBiosource |
0.2mL |
EUR 355 |
PE-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075869-05mL |
MyBiosource |
0.5mL |
EUR 660 |
PE-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075869-1mL |
MyBiosource |
1mL |
EUR 810 |
PE-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075869-5mL |
MyBiosource |
5mL |
EUR 2330 |
Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), Biotinylated |
4-PAE929Hu01-Biotin |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with Biotin. |
Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), Biotinylated |
4-PAE929Hu02-Biotin |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with Biotin. |
Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), APC-Cy7 |
4-PAE929Hu01-APC-Cy7 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with APC-Cy7. |
Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), APC-Cy7 |
4-PAE929Hu02-APC-Cy7 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with APC-Cy7. |
APC-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075870-01mL |
MyBiosource |
0.1mL |
EUR 265 |
APC-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075870-02mL |
MyBiosource |
0.2mL |
EUR 355 |
APC-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075870-05mL |
MyBiosource |
0.5mL |
EUR 660 |
APC-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075870-1mL |
MyBiosource |
1mL |
EUR 810 |
APC-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075870-5mL |
MyBiosource |
5mL |
EUR 2330 |
APC-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075871-01mL |
MyBiosource |
0.1mL |
EUR 265 |
APC-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075871-02mL |
MyBiosource |
0.2mL |
EUR 355 |
APC-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075871-05mL |
MyBiosource |
0.5mL |
EUR 660 |
APC-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075871-1mL |
MyBiosource |
1mL |
EUR 810 |
APC-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075871-5mL |
MyBiosource |
5mL |
EUR 2330 |
Cy3-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075872-01mL |
MyBiosource |
0.1mL |
EUR 265 |
Cy3-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075872-02mL |
MyBiosource |
0.2mL |
EUR 355 |
Cy3-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075872-05mL |
MyBiosource |
0.5mL |
EUR 660 |
Cy3-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075872-1mL |
MyBiosource |
1mL |
EUR 810 |
Cy3-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075872-5mL |
MyBiosource |
5mL |
EUR 2330 |
Cy3-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075873-01mL |
MyBiosource |
0.1mL |
EUR 265 |
Cy3-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075873-02mL |
MyBiosource |
0.2mL |
EUR 355 |
Cy3-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075873-05mL |
MyBiosource |
0.5mL |
EUR 660 |
Cy3-Linked Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
MBS2075873-1mL |
MyBiosource |
1mL |
EUR 810 |
Water-Pipe Smoking Publicity Deregulates a Set of Genes Related to Human Head and Neck Most cancers Growth and Prognosis
- Water-pipe smoking (WPS) is popping into in all probability essentially the most well-liked type of tobacco use among the many many many youth, notably contained in the Coronary heart East, altering cigarettes quickly and turning into a essential danger of tobacco dependancy worldwide. Smoke from WPS accommodates comparable toxins as these current in cigarette smoke and is linked instantly with a variety of sorts of cancers together with lung and head and neck (HN) carcinomas.
- Nonetheless, the underlying molecular pathways and/or objective genes accountable for the carcinogenic course of are nonetheless unknown. On this research, human frequent oral epithelial (HNOE) cells, NanoStringPanCancer Pathways panel of 770 gene transcripts and quantitative real-time polymerase chain response (qRT-PCR) evaluation had been utilized to hunt out differentially expressed genes (DEG) modulated by WPS. In silico evaluation was carried out to analysis the have an effect on of those genes in HN most cancers affected explicit particular person’s biology and consequence. We discovered that WPS can induce the epithelial-mesenchymal transition (EMT: hallmark of most cancers development) of HNOE cells.
- Additional considerably, our evaluation of NanoString revealed 23 genes deregulated beneath the have an effect on of WPS, accountable for the modulation of cell cycle, proliferation, migration/invasion, apoptosis, sign transduction, and inflammatory response. Further evaluation was carried out utilizing qRT-PCR of HNOE WPS-exposed and unexposed cells supported the reliability of our NanoString data.
- Furthermore, we exhibit these DEG to be upregulated in most cancers in distinction with frequent tissue. Utilizing the Kaplan-Meier evaluation, we seen a big affiliation between WPS-deregulated genes and relapse-free survival/full survival in HN most cancers victims. Our findings level out that WPS can modulate EMT together with a set of genes which could possibly be instantly concerned in human HN carcinogenesis, thereby affecting HN most cancers victims’ survival.
A pilot research on the genetic range of Mycobacterium tuberculosis tough strains from tuberculosis victims contained in the Littoral house of Cameroon
Background: The re-emergence of tuberculosis (TB) worldwide, compounded by multi-drug resistance (MDR) of the causative brokers constitutes a big concern to the administration of the illness. Speedy analysis and correct stress identification are pivotal to the administration of the illness. This pilot research investigated the genetic range of Mycobacterium tuberculosis tough (MTBC) strains from TB victims contained in the Littoral house of Cameroon together with their resistance to rifampicin (RIF).
Victims and methods: This was a cross sectional hospital-based research carried out between January and December 2017 and together with 158 isolates from sputum smear constructive of us [105 (66.5%) males and 53 (33.5%) females]. Sputum samples had been examined utilizing Xpert MTB/RIF, adopted by customized on Lowenstein-Jensen medium. Isolates had been additional subjected to molecular characterization utilizing IS6110 typing, deletion evaluation and spoligotyping.
Outcomes: 13 (8.8%) of the 147 isolates with susceptibility outcomes accessible had been proof in the direction of RIF. Drug resistance occurred in 5/50 (10%) feminine in contrast with 8/97 (8.2%) male (OR, 0.81; 0.25-2.62; p = 0.764), and there was no essential distinction all by way of the age ranges (p = 0.448). Nonetheless, RIF resistance was related (OR, 0.18, 95%CI, 0.05-0.69; p = 0.023) with beforehand handled victims [(4/14 (28.6%)] in contrast with new ones [9/133 (6.8%)].
The 150 acknowledged lineages included amongst others 54 (36%) Cameroon, 18 (12%) UgandaI, 32 (21.3%) Haarlem, 17 (11.3%) Ghana, 9(6%) West African 1, 7(4.7%) Delhi/CAS, 4 (2.7%) LAM and three (2%) UgandaII. Of the 150 isolates, a really highly effective cluster was the Cameroon SIT 61, with 43(28.7%) isolates. Six (35.3%) of the 17 UgandaI sub-lineage had been RIF resistant (OR, 9.58; 95%CI, 2.74-33.55, p = 0.001).
Conclusion: The cosmopolitan Littoral house presents with an enormous Mycobacterium tuberculosis (MTB) strains range and the UgandaI sub-lineage attainable related to RIF resistance. Understanding the unfold of this clade by way of surveillance will improve TB administration contained in the house.
Prediction of Clearance of Monoclonal and Polyclonal Antibodies and Non-Antibody Proteins in Youngsters: Utility of Allometric Scaling
Allometric scaling can be utilized for the extrapolation of pharmacokinetic parameters from adults to kids. The target of this research was to foretell clearance of therapeutic proteins (monoclonal and polyclonal antibodies and non-antibody proteins) allometrically in preterm neonates to adolescents. There have been 13 monoclonal antibodies, seven polyclonal antibodies, and 9 therapeutic proteins (non-antibodies) within the research.
The clearance of therapeutic proteins was predicted utilizing the age dependent exponents (ADE) mannequin after which in contrast with the noticed clearance values. There have been in whole 29 therapeutic proteins on this research with 75 observations. The variety of observations with ≤30%, ≤50%, and >50% prediction error was 60 (80%), 72 (96%), and three (4%), respectively.
General, the anticipated clearance values of therapeutic proteins in kids was good. The allometric technique proposed on this manuscript can be utilized to pick out first-in-pediatric dose of therapeutic proteins in pediatric scientific trials.